0000000000322162

AUTHOR

S. Von Haehling

showing 3 related works from this author

The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Li…

2020

Proteins play a crucial role in metabolism, in maintaining fluid and acid-base balance and antibody synthesis. Dietary proteins are important nutrients and are classified into: 1) animal proteins (meat, fish, poultry, eggs and dairy), and, 2) plant proteins (legumes, nuts and soy). Dietary modification is one of the most important lifestyle changes that has been shown to significantly decrease the risk of cardiovascular (CV) disease (CVD) by attenuating related risk factors. The CVD burden is reduced by optimum diet through replacement of unprocessed meat with low saturated fat, animal proteins and plant proteins. In view of the available evidence, it has become acceptable to emphasize the …

AdultMaleDietary proteinWeight lossCardiometabolic Risk Factorsfood and beveragesMiddle AgedRecommended Dietary AllowancesCardiovascular diseasePlant Proteins DietaryCardiovascular disease Cholesterol Dietary protein Metabolic syndrome Weight loss Adult Aged Animal Proteins Dietary Cardiometabolic Risk Factors Cardiovascular Diseases Diet Healthy Expert Testimony Female Humans Male Middle Aged Plant Proteins Dietary Young Adult Recommended Dietary AllowancesMetabolic syndromeYoung AdultCholesterolCardiovascular DiseasesAnimal Proteins DietaryHumansFemaleDiet HealthyExpert TestimonyAged
researchProduct

Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator…

2010

Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide-dependent vasodilation. In 113 patients with chronic heart failure (CHF) and 26 controls, ADMA level was studied in relation to peripheral blood flow and vasodilator capacity. Further, the effects of allopurinol on concentrations of reactive oxygen species (ROS) and ADMA and peripheral vasodilator capacity were tested in a double-blind design. ADMA level was found to be elevated in CHF patients as compared with controls and increased in parallel with New York Heart Association (NYHA) class and exercise capacity (all P < 0.0001). The level of ADMA predicted resting blood flow (P < 0.05) and postischemic vasodilator…

Malemedicine.medical_specialtyHeart diseaseAllopurinolAllopurinolheart failureVasodilationmedicine.disease_causeArgininechemistry.chemical_compoundDouble-Blind Methodendothelial functionInternal medicineMedicineHumansoxidative stressPharmacology (medical)Xanthine oxidaseAgedPharmacologybusiness.industryFree Radical ScavengersMiddle Agedmedicine.diseaseUric AcidVasodilationEndocrinologyCross-Sectional Studieschemistryheart failure; oxidative stress; endothelial functionHeart failureChronic DiseaseUric acidCitrullineFemalebusinessAsymmetric dimethylarginineReactive Oxygen SpeciesOxidative stressmedicine.drug
researchProduct

Cachexia: a therapeutic approach beyond cytokine antagonism

2002

Cachexia is seen in a number of chronic diseases, and it is always associated with a poor prognosis. Irrespective of etiology, the development of cachexia appears to share a common pathophysiological pathway. This includes induction of proteasome-dependent myofibril-degradation, which is thought to be secondary to stimulation by enhanced levels of pro-inflammatory cytokines. Elevation of tumor necrosis factor-alpha (TNFalpha) and other plasma cytokines has been demonstrated in many conditions associated with cachexia. Despite improved pathophysiological understanding, a specific treatment for cachexia has not yet been established. Whilst direct TNFalpha antagonism has therapeutic appeal, th…

CachexiaTumor Necrosis Factor-alphabusiness.industrymedicine.medical_treatmentNF-kappa BImmunosuppressionNF-κBmedicine.diseaseCachexiaTranscription Factor AP-1PathogenesisTherapeutic approachchemistry.chemical_compoundTreatment OutcomeCytokinechemistryImmunologyCytokinesHumansMedicineTumor necrosis factor alphaCardiology and Cardiovascular MedicineAntagonismbusinessImmunosuppressive AgentsInternational Journal of Cardiology
researchProduct